Home
About
Overview
Sharing Data
ORCID
Help
History (104)
Hansen, Piper
Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany.
Buprenorphine, Naloxone Drug Combination
Microvascular brain pathology and late-life motor impairment.
Contribution of TDP and hippocampal sclerosis to hippocampal volume loss in older-old persons.
See All 104 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Contribution of TDP and hippocampal sclerosis to hippocampal volume loss in older-old persons.
Contribution of TDP and hippocampal sclerosis to hippocampal volume loss in older-old persons. Neurology. 2020 01 14; 94(2):e142-e152.
View in:
PubMed
subject areas
Aged, 80 and over
Alzheimer Disease
Atrophy
Female
Hippocampus
Humans
Male
Sclerosis
TDP-43 Proteinopathies
authors with profiles
Konstantinos Arfanakis
Lei Yu
Patricia A Boyle
Julie A Schneider
Robert J Dawe